Wegovy Prior Authorization Made Easier: A Step-By-Step Playbook To Get Approved In 2026

If you've ever felt like getting Wegovy approved is harder than actually taking it, you're not imagining things. Prior authorization (PA) is an insurance checkpoint designed to control cost and confirm "medical necessity," but it often turns into a paperwork puzzle where one missing BMI value, one vague diagnosis, or one unchecked box triggers a denial.

The good news: most denials are fixable, and many are preventable. This playbook walks you through how Wegovy prior authorization typically works in 2026, what to prep before your visit, what your clinician should document, how to submit cleanly, and what to do if you're denied, plus how to protect coverage once you're approved.

A quick note: insurance rules vary by plan and state. Use this as a framework to ask smarter questions and help your clinician submit a stronger request.

How Wegovy Prior Authorization Works (And Why Denials Happen)

Prior authorization is essentially your insurer saying: "Before we pay for this, show us it meets our criteria." For Wegovy (semaglutide for chronic weight management), those criteria usually revolve around three buckets: eligibility, documentation, and safety.

What A Prior Authorization Is Checking For

Most plans are trying to confirm:

1. You meet BMI and indication requirements

• Many plans align with FDA labeling: BMI of 30 kg/m² or higher, or BMI of 27 kg/m² or higher with at least one weight-related condition.
• Some plans set stricter thresholds (for example, requiring BMI 30+ even with comorbidities), or they may require participation in a structured lifestyle program.

2. You have weight-related health risk that justifies treatment

Plans commonly want documentation of comorbidities such as prediabetes, hypertension, dyslipidemia, obstructive sleep apnea, PCOS, or fatty liver disease (NAFLD/MASLD: sometimes termed MASH for the inflammatory subtype).

3. You've attempted lifestyle changes

This is where many PAs get vague. Insurers often expect evidence of diet and activity efforts over a defined period, sometimes 3–6 months.

4. The request is safe and appropriate

Your prescriber typically needs to confirm you don't have key contraindications (for example, personal or family history of medullary thyroid carcinoma or MEN2) and that you're not pregnant or planning pregnancy.

The Most Common Reasons Plans Say "No"

Denials often sound clinical, but the root cause is usually administrative. The most common issues:

• Missing or outdated weights and BMI

A PA that lists a BMI but doesn't show height, weight, and date can get kicked back.

• Criteria mismatch (your plan's rule is different than "typical")

Some plans require step therapy (trying a different medication first) or have specific exclusions.

• Weak or incorrect diagnosis coding

If the ICD-10 code doesn't match what your plan expects, the claim can fail even if your story is compelling. Some plans also want comorbidity codes plus to an obesity code.

• No lifestyle program documentation

"Patient has tried diet and exercise" can be too thin for certain insurers.

• Incomplete forms or missing clinical notes

A surprisingly common problem: the PA form is submitted without the most recent visit note, labs, or a clear problem list.

• Safety boxes left blank

If the form asks about contraindications and the prescriber leaves it empty, insurers may treat it as "unknown" and deny.

Prep Before Your Appointment: The Checklist That Prevents Delays

The fastest approvals tend to happen when you walk into your appointment with the same mindset you'd bring to taxes: bring the documents, reduce ambiguity, and don't rely on memory.

Insurance Details To Gather First (Formulary, PA Criteria, Step Therapy)

Before you see your clinician (or before they submit the PA), try to gather:

• Is Wegovy on your plan's formulary?

Look for the drug list (sometimes called a formulary) in your insurance portal.

• The plan's Wegovy PA criteria

Many insurers post the exact requirements as a PDF. If you can't find it, call the number on your card and ask:

• What are the BMI thresholds?
• Which comorbidities qualify?
• Is a documented lifestyle program required (and for how long)?
• Is step therapy required?
• What documentation is required for reauthorization?
• Pharmacy benefit manager (PBM) rules

Sometimes the "real rules" sit with the PBM rather than the insurer's medical policy.

• Tools that can help

Novo Nordisk's NovoCare resources can help you identify coverage pathways and may clarify whether PA is required for your plan.

Medical History To Bring (Weights, Labs, Comorbidities, Prior Attempts)

Bring a one-page "PA-ready snapshot." It doesn't need to be fancy: it needs to be specific.

Include:

• Your height and recent weights with dates

If you have weights from multiple time points (for example, 6–12 months), bring them. Trends help.

• Your most relevant labs

Commonly helpful:

• A1c and/or fasting glucose (prediabetes/diabetes risk)
• Lipids (LDL, triglycerides)
• Liver enzymes (ALT/AST) and any imaging or fibrosis scoring if you've been evaluated for fatty liver disease
• Blood pressure readings or hypertension diagnosis history
• Diagnosed comorbidities

If you have obstructive sleep apnea, bring your sleep study summary. If you have PCOS, bring prior documentation (ultrasound findings, hormone labs, clinical diagnosis notes).

• Your prior weight-loss attempts

Plans often want evidence of prior efforts. Examples that can count:

• Documented nutrition counseling visits
• A structured program (even virtual)
• Supervised exercise program
• Prior anti-obesity medications and why they were ineffective or not tolerated

The key is "documented." If it's not in a record, it can be hard for your clinician to use it in a PA.

GLP-1 Reality Check: Side Effects, Contraindications, And Safety Flags

This is the part many people skip, but it can prevent back-and-forth.

Be ready to discuss:

• Contraindications and major safety flags

Your clinician may need to document screening for:

• Personal/family history of medullary thyroid carcinoma (MTC) or MEN2
• History of pancreatitis (varies by clinician and plan how this is handled)
• Gallbladder disease history
• Pregnancy, breastfeeding, or plans to conceive
• Medication list and interactions

Especially if you're on insulin, sulfonylureas, or other agents that can affect blood sugar.

• Side effect planning

Ironically, insurers sometimes want reassurance that you can tolerate therapy and stay adherent. Having a plan for nausea, constipation, and reflux can matter later for renewals.

And from a real-life standpoint: if you're already prone to constipation or bloating, GLP-1s can amplify that because they slow gastric emptying and gut motility (in plain English: food moves through your stomach and intestines more slowly). Planning ahead makes staying on therapy easier.

What Your Clinician Should Document To Meet Typical Criteria

You shouldn't have to "coach" your clinician, but it's completely reasonable to ask: "What does my insurance usually require for Wegovy prior authorization, and what will you include?"

Here's what typically strengthens a PA.

BMI And Diagnosis Coding Basics (Obesity, Overweight With Comorbidities)

Most approvals hinge on two facts that must be clearly stated and dated:

• Your BMI (with height and weight)

Insurers often want the BMI documented at a recent visit.

• The diagnosis that matches the indication

Common categories:

• Obesity (BMI 30+)
• Overweight (BMI 27–29.9) with qualifying comorbidity

Coding details matter because insurers often run automated checks. If the request doesn't "map" cleanly to policy, it may be denied even if clinically appropriate.

Comorbidities That Strengthen A Case (Prediabetes, Sleep Apnea, PCOS, NAFLD)

Your clinician's note is stronger when it connects weight to measurable health risk.

Examples of commonly accepted comorbidities and supporting documentation:

• Prediabetes

Document A1c values and dates (for example, A1c in the prediabetes range). If you've had gestational diabetes in the past, that history can also be relevant.

• Obstructive sleep apnea

Include diagnosis and whether you use CPAP (adherence can underscore medical impact).

• PCOS

Document clinical history (irregular cycles, hyperandrogen symptoms), labs when available, and prior treatments.

• NAFLD/MASLD (fatty liver disease)

Include imaging results (ultrasound, FibroScan) or relevant labs. Some clinicians use noninvasive scores (like FIB-4 or ELF testing) to quantify risk.

• Hypertension and dyslipidemia

Document diagnoses, meds, and recent readings/lipids.

If you have established cardiovascular disease (history of MI, stroke, or documented atherosclerotic disease), that can materially strengthen medical necessity in some plan frameworks.

Lifestyle Program Proof: What Counts And How To Show It

A common insurer expectation is "failed adequate trial of lifestyle intervention." What counts depends on your plan, but typically includes:

• Nutrition counseling visits documented in your chart
• A structured program with dates (in-person or virtual)
• Clinician-documented calorie or macronutrient plan and follow-up
• Activity plan with follow-up notes
• Weight trend showing insufficient response to lifestyle alone

What helps most is specificity:

• Timeframe (example: 6 months)
• What you did (example: reduced-calorie plan, resistance training 3x/week)
• Your measured outcome (example: weight decreased by X pounds, then plateaued)

Even if you've been working hard for years, the PA process often treats anything not clearly documented as if it didn't happen. It's frustrating. It's also fixable with better notes.

Women 35–55: Documentation Tips For Perimenopause, Menopause, And Weight Gain

If you're a woman in the 35–55 range, you may have experienced a very specific kind of weight change: the "nothing changed but everything changed" pattern. Sleep shifts. Stress tolerance changes. Recovery slows. Muscle mass drifts down. And the scale creeps up anyway.

Perimenopause and menopause can influence body composition and insulin sensitivity (how effectively your body handles glucose). But insurance companies don't approve medications based on "hormones are changing." They approve based on defined criteria and documented risk.

How To Discuss Hormone Shifts Without Triggering Coverage Confusion

When you talk with your clinician, it can help to frame the story like this:

• Describe the timeline and pattern

Example: "Over 18 months, even though consistent nutrition and exercise, I gained X pounds and my waist increased."

• Acknowledge the life stage without making it the sole reason

Perimenopause can be context, but not the justification.

• Anchor the request in measurable medical criteria

BMI plus comorbidities, documented lifestyle attempts, and clinical risk markers.

Why this matters: some PAs get messy when the narrative becomes too generalized ("menopause weight gain") rather than tied to specific diagnoses like obesity, prediabetes, hypertension, dyslipidemia, or sleep apnea.

Metabolic Risk Markers To Highlight With Your Clinician

If you're in perimenopause/menopause, the strongest PA documentation often includes:

• A1c trends or fasting glucose changes

Even small upward drift can support metabolic risk.

• Lipid changes

Rising LDL or triglycerides can be part of the cardiometabolic picture.

• Blood pressure

New or worsening hypertension is common in midlife.

• Waist circumference and body composition concerns

Insurers don't always require waist measurements, but clinicians can document central adiposity (more abdominal fat), which is metabolically meaningful.

• Sleep quality and sleep apnea screening

If you snore, feel unrefreshed, or have daytime sleepiness, ask whether sleep apnea evaluation is appropriate. A confirmed diagnosis can strengthen medical necessity.

If you're working with a clinician experienced in both metabolic health and hormones (including menopause care), the documentation tends to be cleaner because the story is both human and medically precise.

Submitting The PA: Practical Tips That Speed Up Approval

You can have perfect medical eligibility and still get delayed by submission errors. Clean paperwork is underrated.

Getting The Right Form, Route, And Quantity (Dose Escalation, Refills, Duration)

Make sure your clinic submits:

• The correct plan-specific PA form

Many plans reject "generic" forms.

• The right submission route

Some require electronic portals: others accept fax. If your clinic uses ePA (electronic prior authorization), it can be faster, but only if the data fields match the plan's requirements.

• Correct dosing plan and quantity

Wegovy is typically titrated (dose-escalated) over time. PAs may need to reflect:

• Dose strength requested
• Quantity that matches packaging (often a 28-day supply)
• Number of refills and intended duration of therapy

A common snag is a mismatch between the dose written, the quantity requested, and what the plan expects for a 28-day supply.

Avoiding Common Admin Errors (Missing Notes, Wrong NDC, Incomplete Fields)

These are the avoidable mistakes that trigger denials or "pending" status:

• Missing clinical note attachments

Your most recent visit note that documents BMI, comorbidities, and prior attempts can be the difference between approve and deny.

• Wrong or missing NDC

NDC (National Drug Code) identifies the exact product. Using the wrong one can route the request incorrectly.

• Incomplete fields

If the form asks for start date, BMI calculation, lifestyle program details, or contraindication screening, blanks can equal delays.

• Contradictory information

Example: the form says BMI 31, but the chart note shows BMI 28, or the dates don't align.

If you want to be proactive, you can ask the clinic staff: "Can you confirm the PA includes my latest weight/BMI, my qualifying conditions, and the last visit note?" You're not being difficult, you're preventing a predictable delay.

Timelines, Follow-Ups, And How To Track The Request

Many plans return a decision in roughly 1–7 business days, but it varies.

Practical tracking steps:

• Ask for the submission date and method (portal vs fax)
• Ask for the reference number (if available)
• Check your insurer portal for PA status
• If nothing updates after several business days, call the insurer and ask:
• Has the PA been received?
• Is it missing information?
• What is the expected decision date?

If it's marked "pending additional information," ask what exactly is missing and whether it must come from the prescriber vs. whether you can upload a record.

If You’re Denied: How To Win An Appeal

A denial feels personal, but it's usually procedural: the plan is saying the submission didn't prove it met their policy. Your job in an appeal is to answer their policy as directly as possible.

Decode The Denial Letter And Match It To The Plan's Criteria

Start by reading the denial letter like a checklist.

Common denial categories:

• "Does not meet BMI criteria"

Check whether the plan uses a different BMI cutoff than expected, or whether your BMI was documented incorrectly.

• "No qualifying comorbidity documented"

This often means the comorbidity exists, but wasn't coded or supported with labs/diagnostic evidence.

• "No documentation of lifestyle program"

This is a documentation problem, not a moral judgment. Gather dates, visit notes, or program receipts.

• "Step therapy required"

The plan may want you to try a different medication first or document why it's not appropriate.

Then pull the plan's published PA criteria and align your appeal to each bullet point.

Build A Strong Appeal Packet (Letter Of Medical Necessity, Evidence, Records)

A strong appeal packet is organized and boring (in the best way). It typically includes:

• A Letter of Medical Necessity (LMN) from your clinician

It should include:

• Your BMI with dated height/weight
• Qualifying diagnoses and codes
• Relevant comorbidities with objective support (A1c, BP, lipids, sleep study)
• Prior lifestyle interventions (with timeframe and outcomes)
• Rationale for Wegovy vs alternatives
• Safety screening and monitoring plan
• Key records

Include only what's necessary:

• Recent visit note
• Labs
• Problem list
• Program documentation
• Evidence support (when appropriate)

Some clinicians include brief references to clinical guidelines and FDA indication language. The goal isn't to "argue," it's to show alignment with accepted medical standards.

A practical tip: ask your clinician's office to include a one-page cover sheet that lists every attachment. Appeals get handled by humans under time pressure, and clarity helps.

Peer-To-Peer Reviews, External Review, And Employer Plan Options

If an appeal is denied again, options may include:

• Peer-to-peer review

Your clinician speaks directly with the insurer's medical reviewer. This can be effective when the case is clinically clear but documentation or interpretation was the issue.

• External review

Depending on your plan type and state rules, you may be eligible for an independent external review.

• Employer-sponsored plan routes

If your insurance is through an employer, HR or benefits teams sometimes have a broker or benefits manager who can clarify coverage policy or advocate for exceptions, especially when the denial is based on a plan exclusion rather than medical criteria.

None of this is fast, but it's often worth it when the denial is fixable and the clinical need is real.

After Approval: Staying Covered At Refills And Renewals

Approval is a milestone, not the finish line. Many Wegovy authorizations last about 6–12 months, and reauthorization often requires proof that the medication is working and that you're staying engaged in follow-up care.

Reauthorization Requirements (Weight Loss %, Adherence, Follow-Up Visits)

Common reauthorization requirements include:

• Evidence of clinical response

Some plans look for a minimum percent weight loss (often 4–5% or more) within a certain timeframe. Your plan may define the exact threshold.

• Adherence to therapy

This can mean consistent refills and no prolonged gaps.

• Ongoing lifestyle efforts and follow-up

Regular visits help your clinician document progress and address tolerability.

If you're someone who loses inches before pounds (very common), ask your clinician to document both scale weight and body measurements, along with metabolic labs.

Managing Side Effects So You Don't Stop And Lose Coverage

From a coverage standpoint, stopping and restarting can complicate reauthorization. From a human standpoint, unmanaged GI side effects can make you miserable.

GLP-1 medications commonly cause nausea, constipation, reflux, bloating, and a "too full" sensation because they slow gastric emptying and gut motility. The most helpful approach is to:

• Tell your clinician early if side effects are escalating
• Discuss whether dose escalation timing is appropriate for you
• Ensure hydration, protein intake, and fiber strategy are realistic for your GI tolerance

If you're prone to IBS-like symptoms or sensitive digestion, your tolerability plan matters. A refill is easier to defend when your chart shows you're managing side effects thoughtfully rather than discontinuing repeatedly.

Documenting Progress: Weight, Measurements, Labs, And GI Tolerance

For renewals, documentation is your friend. Consider tracking:

• Weight (weekly or biweekly) and date
• Waist circumference or hip/waist measurements (monthly)
• Key labs every few months as clinically appropriate (A1c, lipids, liver enzymes)
• Side effect notes

Simple is fine: nausea days, constipation severity, reflux frequency, trigger foods.

If you ever need to appeal a renewal denial, a clear record of benefit and tolerability makes the argument much easier.

Digestive discomfort is one of the most common reasons people struggle with GLP-1 medications. Targeted nutrition support can make a real difference in tolerability. Casa de Sante's physician-formulated digestive enzymes, synbiotics, and motility support supplements are designed specifically for sensitive stomachs on GLP-1 therapy. See what's available at casadesante.com.

This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before making changes to your treatment plan.

Conclusion

Wegovy prior authorization is rarely about "deserving" care. It's about matching your real health story to your plan's written criteria, with clean documentation and the right codes, dates, and supporting records.

If you take one thing from this: treat the PA like a packet, not a conversation. Bring your weights and labs, confirm your plan's criteria, make sure comorbidities are explicitly documented, and keep follow-up notes tight once you're approved.

And if you get denied, don't assume it's the end. Many denials are simply a request to be more specific, and specificity is something you can control.

Wegovy Prior Authorization Tips - Frequently Asked Questions

What are the key requirements for Wegovy prior authorization approval?

Wegovy prior authorization typically requires documenting a BMI of 27–30 kg/m² or higher with weight-related comorbidities, proof of prior lifestyle changes (diet and exercise), specific diagnosis codes for obesity or related conditions, and safety screening for contraindications.

Why does Wegovy prior authorization get denied, and how can I avoid it?

Most denials occur due to missing or outdated BMI data, incorrect diagnosis codes, incomplete forms, lack of documented lifestyle attempts, or missing safety information like contraindications. Preparing a complete medical history and ensuring your clinician includes all required details can prevent delays.

How should I prepare for my appointment to improve the chances of Wegovy PA approval?

Gather your latest height, weights with dates, labs relevant to comorbidities (like A1c, lipids), documentation of prior weight-loss efforts, and verify your insurance plan’s PA criteria and formulary status using tools like NovoCare before your visit.

What documentation should my clinician include to strengthen a Wegovy prior authorization request?

Your clinician should document a recent BMI with height and weight, use correct obesity-related ICD-10 codes, list qualifying comorbidities with objective lab or test evidence, detail prior lifestyle programs including dates, and confirm no contraindications such as thyroid cancers or pregnancy.

How can women aged 35–55 frame their perimenopausal weight gain in a Wegovy PA request?

Women in this age group should describe their weight gain timeline with consistent nutrition and exercise, avoid citing menopause alone as justification, and anchor their request in measurable metabolic risk markers like rising A1c, hypertension, or fatty liver disease documented with labs.

What steps should I take if my Wegovy prior authorization is denied?

Carefully review the denial letter to identify missing criteria, then submit an appeal with a detailed Letter of Medical Necessity from your clinician, including all relevant documentation. Consider peer-to-peer reviews and external appeals if needed to support your case.